Chugai Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that operates in the Large Pharma sector. The company is committed to developing innovative medicines that meet the needs of patients worldwide. Chugai Pharmaceutical Co., Ltd. was founded in 1925 and is headquartered in Tokyo, Japan. The company has a global presence and operates in various countries, including the United States, Europe, and Asia.

Decarbonisation is a key focus area for Chugai Pharmaceutical Co., Ltd. The company recognizes the impact of climate change on the environment and is committed to reducing its carbon footprint. Chugai Pharmaceutical Co., Ltd. has set a target to reduce its greenhouse gas emissions by 30% by 2030, compared to its 2013 levels. The company is working towards achieving this target by implementing various measures, such as energy efficiency improvements, use of renewable energy, and decarbonization of its supply chain.

Corporate energy is another area of focus for Chugai Pharmaceutical Co., Ltd. The company is committed to reducing its energy consumption and increasing the use of renewable energy. Chugai Pharmaceutical Co., Ltd. has implemented various measures to reduce its energy consumption, such as the installation of energy-efficient lighting and equipment, and the optimization of its production processes. The company has also increased the use of renewable energy, such as solar and wind power, in its operations.

Corporate PPA (Power Purchase Agreement) is a key strategy for Chugai Pharmaceutical Co., Ltd. to increase the use of renewable energy in its operations. The company has signed a Corporate PPA with a renewable energy provider to purchase renewable energy for its operations. This agreement ensures a stable and predictable supply of renewable energy for the company, while also contributing to the decarbonization of the energy sector.

Renewable energy is a key focus area for Chugai Pharmaceutical Co., Ltd. The company recognizes the importance of renewable energy in reducing greenhouse gas emissions and mitigating the impact of climate change. Chugai Pharmaceutical Co., Ltd. has set a target to increase its use of renewable energy to 50% by 2030, compared to its 2013 levels. The company is working towards achieving this target by implementing various measures, such as the installation of solar panels and wind turbines, and the use of biomass and geothermal energy.

Chugai Pharmaceutical Co., Ltd. has implemented various initiatives to reduce its carbon footprint and increase the use of renewable energy in its operations. The company has installed solar panels on the roofs of its facilities, which generate renewable energy to power its operations. Chugai Pharmaceutical Co., Ltd. has also installed wind turbines at its facilities, which generate renewable energy to power its operations. The company has also implemented energy efficiency measures, such as the use of energy-efficient lighting and equipment, and the optimization of its production processes.

Chugai Pharmaceutical Co., Ltd. has also implemented measures to decarbonize its supply chain. The company has established a Green Procurement Policy, which requires its suppliers to comply with environmental standards and regulations. Chugai Pharmaceutical Co., Ltd. also works closely with its suppliers to identify opportunities to reduce greenhouse gas emissions and increase the use of renewable energy in the supply chain.

In conclusion, Chugai Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that operates in the Large Pharma sector. The company is committed to developing innovative medicines that meet the needs of patients worldwide. Decarbonisation, corporate energy, corporate PPA, and renewable energy are key focus areas for Chugai Pharmaceutical Co., Ltd. The company has implemented various measures to reduce its carbon footprint and increase the use of renewable energy in its operations. Chugai Pharmaceutical Co., Ltd. is committed to contributing to the decarbonization of the energy sector and mitigating the impact of climate change.